Pulmatrix Stock Investor Sentiment
| PULM Stock | USD 8.38 0.06 0.71% |
About 56% of Pulmatrix's investor base is looking to short. The analysis of overall sentiment of trading Pulmatrix stock suggests that many investors are alarmed at this time. Pulmatrix's investing sentiment overview a quick insight into current market opportunities from investing in Pulmatrix. Many technical investors use Pulmatrix stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Pulmatrix | Build AI portfolio with Pulmatrix Stock |
Pulmatrix Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Pulmatrix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Pulmatrix's Stock prices. Below is the latest headlines and news related to Pulmatrix Stock. Current markets are slightly bullish. About 51% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Pulmatrix that are available to investors today. This information is accessible both publicly - through Pulmatrix's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Pulmatrix-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Pulmatrix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmatrix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmatrix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmatrix alpha.
Pulmatrix Largest EPS Surprises
Earnings surprises can significantly impact Pulmatrix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-05-11 | 2018-03-31 | -0.19 | -0.24 | -0.05 | 26 | ||
2023-08-10 | 2023-06-30 | -1.23 | -1.04 | 0.19 | 15 | ||
2021-05-11 | 2021-03-31 | -2 | -1.8 | 0.2 | 10 | ||
2023-03-30 | 2022-12-31 | -1.44 | -1.14 | 0.3 | 20 | ||
2018-08-03 | 2018-06-30 | -1.7 | -1.3 | 0.4 | 23 | ||
2024-03-28 | 2023-12-31 | -1.04 | -0.57 | 0.47 | 45 |
There is far too much social signal, news, headlines, and media speculation about Pulmatrix that are available to investors today. This information is accessible both publicly - through Pulmatrix's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Pulmatrix-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Pulmatrix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pulmatrix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pulmatrix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pulmatrix alpha.
Pulmatrix Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Mcguire Terrance of 124000 shares of Pulmatrix at 0.468 subject to Rule 16b-3 | 03/14/2025 |
2 | Pulmatrix Announces Divestment Plan for Assets - citybiz | 03/21/2025 |
3 | Pulmatrix Reports 2018 Financial Results Provides 2019 Outlook on Pulmonary Disease Pipeline - Marketscreener.com | 03/28/2025 |
4 | Disposition of tradable shares by Siegert Michelle of Pulmatrix subject to Rule 16b-3 | 04/11/2025 |
5 | Acquisition by Raad Teofilo David of 741000 shares of Pulmatrix at 0.468 subject to Rule 16b-3 | 05/07/2025 |
6 | Acquisition by Cabell Christopher of 1700 shares of Pulmatrix subject to Rule 16b-3 | 05/09/2025 |
7 | Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets PULM ... | 05/15/2025 |
Check out Pulmatrix Hype Analysis, Pulmatrix Correlation and Pulmatrix Performance. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.35) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.